These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 22133092)

  • 1. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.
    Martin E; Mukherjee P
    J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR models for predicting the similarity in binding profiles for pairs of protein kinases and the variation of models between experimental data sets.
    Sheridan RP; Nam K; Maiorov VN; McMasters DR; Cornell WD
    J Chem Inf Model; 2009 Aug; 49(8):1974-85. PubMed ID: 19639957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in kinase selectivity: insights for target class-focused library screening.
    Posy SL; Hermsmeier MA; Vaccaro W; Ott KH; Todderud G; Lippy JS; Trainor GL; Loughney DA; Johnson SR
    J Med Chem; 2011 Jan; 54(1):54-66. PubMed ID: 21128601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.
    Sciabola S; Stanton RV; Wittkopp S; Wildman S; Moshinsky D; Potluri S; Xi H
    J Chem Inf Model; 2008 Sep; 48(9):1851-67. PubMed ID: 18717582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surrogate AutoShim: predocking into a universal ensemble kinase receptor for three dimensional activity prediction, very quickly, without a crystal structure.
    Martin EJ; Sullivan DC
    J Chem Inf Model; 2008 Apr; 48(4):873-81. PubMed ID: 18380448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.
    Tintori C; Magnani M; Schenone S; Botta M
    Eur J Med Chem; 2009 Mar; 44(3):990-1000. PubMed ID: 18722033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
    Zeng H; Zhang H
    J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile-QSAR and Surrogate AutoShim protein-family modeling of proteases.
    Mukherjee P; Martin E
    J Chem Inf Model; 2012 Sep; 52(9):2430-40. PubMed ID: 22607621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinase inhibitor recognition by use of a multivariable QSAR model.
    Sprous DG; Zhang J; Zhang L; Wang Z; Tepper MA
    J Mol Graph Model; 2006 Jan; 24(4):278-95. PubMed ID: 16253531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential choline kinase inhibitors: a molecular modeling study of bis-quinolinium compounds.
    Srivani P; Sastry GN
    J Mol Graph Model; 2009 Feb; 27(6):676-88. PubMed ID: 19147382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel 3D-QSAR combination approach for screening and optimizing B-Raf inhibitors in silico.
    Shih KC; Lin CY; Zhou J; Chi HC; Chen TS; Wang CC; Tseng HW; Tang CY
    J Chem Inf Model; 2011 Feb; 51(2):398-407. PubMed ID: 21182293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: an insight into the criteria for selectivity.
    Dessalew N; Bharatam PV
    Eur J Med Chem; 2007 Jul; 42(7):1014-27. PubMed ID: 17335939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical studies of QSAR and molecular design on a novel series of ethynyl-3-quinolinecarbonitriles as SRC inhibitors.
    Fang DQ; Wu WJ; Zhang R; Zeng GH; Zheng KC
    Chem Biol Drug Des; 2012 Jul; 80(1):134-47. PubMed ID: 22429605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors.
    Marzaro G; Chilin A; Guiotto A; Uriarte E; Brun P; Castagliuolo I; Tonus F; González-Díaz H
    Eur J Med Chem; 2011 Jun; 46(6):2185-92. PubMed ID: 21447431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. kappa Nearest neighbors QSAR modeling as a variational problem: theory and applications.
    Itskowitz P; Tropsha A
    J Chem Inf Model; 2005; 45(3):777-85. PubMed ID: 15921467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fingerprint-based clustering applied to define a QSAR model use radius.
    Sprous DG
    J Mol Graph Model; 2008 Sep; 27(2):225-32. PubMed ID: 18556228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of kinase inhibitor fragments.
    Bamborough P; Brown MJ; Christopher JA; Chung CW; Mellor GW
    J Med Chem; 2011 Jul; 54(14):5131-43. PubMed ID: 21699136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.